| Company | Date | Position | Consensus β | Price Target β | 1-Yr Return | vs S&P 500 β |
|---|---|---|---|---|---|---|
|
AVTR
Avantor
|
Oct 29, 2026 | HOLD |
Buy
+4.5% avg upside
27 analysts
|
$17.00
5.92% Upside
|
-9.2% | Β· |
|
ICLR
Icon
|
Oct 29, 2026 | BUY |
Strong Buy
-1.8% avg upside
28 analysts
|
$250.00
18.33% Upside
|
-5.0% | Β· |
|
A
Agilent
|
Oct 26, 2026 | BUY |
Strong Buy
-8.0% avg upside
35 analysts
|
$190.00
8.64% Upside
|
-0.7% | Β· |
|
FTRE
Fortrea Holdings Inc.
|
Oct 15, 2026 | BUY |
Buy
+8.3% avg upside
13 analysts
|
$25.00
17.33% Upside
|
-8.4% | Β· |
|
ATR
AptarGroup
|
Oct 07, 2026 | BUY |
Strong Buy
+1.5% avg upside
16 analysts
|
$150.00
9.30% Upside
|
+18.3% | Β· |
|
STVN
Stevanato Group
|
Oct 07, 2026 | HOLD |
Strong Buy
+38.1% avg upside
14 analysts
|
$22.00
13.62% Upside
|
-33.4% | Β· |
|
CRL
Charles River Labs
|
Sep 25, 2026 | BUY |
Strong Buy
-28.4% avg upside
36 analysts
|
$320.00
11.00% Downside
|
+15.1% | Β· |
|
TMO
Thermo Fisher
|
Sep 25, 2026 | BUY |
Strong Buy
-5.2% avg upside
40 analysts
|
$720.00
3.39% Upside
|
+2.9% | Β· |
|
CON
Concentra Group Holdings Parent, Inc.
|
Aug 10, 2026 | BUY |
Strong Buy
+0.7% avg upside
14 analysts
|
$41.00
1.49% Upside
|
+28.5% | Β· |
|
WAT
Waters
|
Aug 05, 2026 | HOLD |
Strong Buy
-12.6% avg upside
31 analysts
|
$400.00
13.63% Downside
|
+14.9% | Β· |
|
MEDP
Medpace Holdings
|
Jul 23, 2026 | HOLD |
Buy
-17.2% avg upside
18 analysts
|
$535.00
17.89% Downside
|
+8.2% | Β· |
|
DHR
Danaher
|
Jul 22, 2026 | BUY |
Strong Buy
-4.4% avg upside
47 analysts
|
$240.00
3.27% Upside
|
+28.8% | Β· |
|
TECH
Bio-Techne
|
Jun 26, 2026 | HOLD |
Hold
+16.1% avg upside
21 analysts
|
$73.00
0.52% Upside
|
+2.5% | Β· |
|
MRVI
Maravai Lifesciences Holdings
|
May 08, 2026 | BUY |
Strong Buy
+99.5% avg upside
18 analysts
|
$6.00
23.16% Downside
|
+43.9% | Β· |
|
TXG
10x Genomics
|
May 08, 2026 | HOLD |
Buy
-7.5% avg upside
19 analysts
|
$23.00
67.17% Downside
|
+171.2% | Β· |
|
WST
West Pharmaceutical Services
|
Feb 13, 2026 | BUY |
Strong Buy
-6.0% avg upside
18 analysts
|
$315.00
23.68% Downside
|
+59.8% | Β· |
|
IQV
IQVIA Holdings
|
Jul 29, 2025 | BUY |
Strong Buy
-2.5% avg upside
40 analysts
|
$220.00
17.75% Downside
|
+27.3% | Β· |
|
RGEN
Repligen
|
Aug 16, 2024 | BUY |
Strong Buy
+1.2% avg upside
25 analysts
|
$175.00
1.10% Downside
|
-15.7% | Β· |
|
EHC
Encompass Health
|
Sep 16, 2019 | HOLD |
Strong Buy
-11.5% avg upside
23 analysts
|
$70.00
48.59% Downside
|
+2.3% | Β· |
|
ILMN
Illumina
|
Jan 17, 2014 | BUY |
Buy
-10.1% avg upside
32 analysts
|
$140.00
40.77% Downside
|
+34.8% | Β· |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.